Shiga toxin pathogenesis: Kidney complications and renal failure

Current Topics in Microbiology and Immunology

Volumn 357, Issue , 2012, Pages 105-136

  Obrig, Tom G ^a   Karpman, Diana ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

HUS; Kidney; LPS; Renal failure; Shiga toxin; STEC

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPID GB3; HEMOLYSIN; NITRIC OXIDE; SHIGA TOXIN; TOXIN ANTIBODY; UNCLASSIFIED DRUG; VACCINE; VEROTOXIN 2; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; BACTERIUM ISOLATE; BLOOD CLOTTING; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL SEPARATION; CIRCULATION; DEHYDRATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; ERYTHROCYTE; ESCHERICHIA COLI INFECTION; FIBRINOLYSIS; FLUID BALANCE; GLOMERULUS; HEMOLYTIC UREMIC SYNDROME; HENLE LOOP; HOST CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY FAILURE; KIDNEY TUBULE CELL; KIDNEY VEIN THROMBOSIS; MESANGIUM CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOSIS; TOXIN SYNTHESIS;

BLOOD CELLS; FIBRINOLYSIS; GLYCOLIPIDS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFLAMMATION; KIDNEY; LIPOPOLYSACCHARIDES; RENAL INSUFFICIENCY; SHIGA TOXIN; SPHINGOLIPIDS; THROMBOSIS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS);

EID: 84857829010     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2011_172     Document Type: Article

References (250)

1. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782-787
2. Ahn CK, Holt NJ, Tarr PI (2009) Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years? Adv Exp Med Biol 634:1-17
3. Akiyoshi DE, Rich CM, O'Sullivan-Murphy S, Richard L, Dilo J, Donohue-Rolfe A, Sheoran AS, Chapman-Bonofiglio S, Tzipori S (2005) Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells. Infect Immun 73:4054-4061 (Pubitemid 40923145)
4. Appiani AC, Edefonti A, Bettinelli A, Cossu MM, Paracchini ML, Rossi E (1982) The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome. Clin Nephrol 17:195-199 (Pubitemid 12157354)
5. Arfilli V, Carnicelli D, Rocchi L, Ricci F, Pagliaro P, Tazzari PL, Brigotti M (2010) Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. Biochem J 432:173-180
6. Barrett TJ, Potter ME, Wachsmuth IK (1989) Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 57:3434-3437 (Pubitemid 19259873)
7. Batsford S, Duermueller U, Seemayer C, Mueller C, Hopfer H, Mihatsch M (2011) Protein level expression of Toll-like receptors 2, 4 and 9 in renal disease. Nephrol Dial Transplant 26:1413-1416
8. Bauer ME, Welch RA (1996) Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect Immun 64:167-175
9. Bens M, Vandewalle A (2008) Cell models for studying renal physiology. Pflugers Arch 457:1-15
10. Benz K, Amann K (2009) Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS)/thrombocytic thrombopenic purpura (TTP). Thromb Haemost 101:265-270
11. Bergstein JM, Riley M, Bang NU (1992) Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 327:755-759
12. Betz J, Bielaszewska M, Thies A, Humpf HU, Dreisewerd K, Karch H, Kim KS, Friedrich AW, Muthing J (2011) Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: association with membrane lipid raft microdomains that differ by their stability to cholesterol depletion. J Lipid Res 52:618-634
13. Beutler B, Poltorak A (2000) Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur Cytokine Netw 11:143-152
14. Bitzan M, Richardson S, Huang C, Boyd B, Petric M, Karmali MA (1994) Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect Immun 62:3337-3347 (Pubitemid 24232119)
15. Bitzan M, Bickford BB, Foster GH (2004) Verotoxin (Shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome. J Am Soc Nephrol 15:2334-2343 (Pubitemid 39159333)
16. Bolignano D, Coppolino G, Lacquaniti A, Buemi M (2010) From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 40: 273-276
17. Boyd B, Lingwood C (1989) Verotoxin receptor glycolipid in human renal tissue. Nephron 51:207-210 (Pubitemid 19037693)
18. Brigotti M, Carnicelli D, Ravanelli E, Barbieri S, Ricci F, Bontadini A, Tozzi AE, Scavia G, Caprioli A, Tazzari PL (2008) Interactions between Shiga toxins and human polymorphonuclear leukocytes. J Leukoc Biol 84:1019-1027
19. Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Barbieri S, Rocchi L, Arfilli V, Scavia G, Ricci F, Bontadini A, Alfieri RR, Petronini PG, Pecoraro C, Tozzi AE, Caprioli A (2010) Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J Leukoc Biol 88:201-210
20. Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Rocchi L, Arfilli V, Scavia G, Minelli F, Ricci F, Pagliaro P, Ferretti AV, Pecoraro C, Paglialonga F, Edefonti A, Procaccino MA, Tozzi AE, Caprioli A (2011) Clinical Relevance of Shiga Toxin Concentrations in the Blood of Patients With Hemolytic Uremic Syndrome. Pediatr Infect Dis J 30:486-490
21. Buelli S, Abbate M, Morigi M, Moioli D, Zanchi C, Noris M, Zoja C, Pusey CD, Zipfel PF, Remuzzi G (2009) Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. Kidney Int 75:1050-1059
22. Calderon Toledo C, Rogers TJ, Svensson M, Tati R, Fischer H, Svanborg C, Karpman D (2008) Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol 173:1428-1439
23. Caprioli J, Remuzzi G, Noris M (2010) Thrombotic microangiopathies: from animal models to human disease and cure. Contrib Nephrol 169:337-350
24. Caprioli J, Remuzzi G, Noris M (2011) Thrombotic microangiopathies: from animal models to human disease and cure. Contrib Nephrol 169:337-350
25. Chaisri U, Nagata M, Kurazono H, Horie H, Tongtawe P, Hayashi H, Watanabe T, Tapchaisri P, Chongsa-nguan M, Chaicumpa W (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31:59-67 (Pubitemid 32681691)
26. Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346:23-32 (Pubitemid 34438916)
27. Cicala C, Santacroce C, Itoh H, Douglas GJ, Page CP (1997) A study on rat platelet responsiveness following intravenous endotoxin administration. Life Sci 60:PL31-PL38
28. Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL (2005) Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25:536-540 (Pubitemid 41816047)
29. Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2010) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117-122
30. Cohen A, Hannigan GE, Williams BR, Lingwood CA (1987) Roles of globotriosyl-and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem 262:17088-17091
31. Cohen A, Madrid-Marina V, Estrov Z, Freedman MH, Lingwood CA, Dosch HM (1990) Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol 2:1-8 (Pubitemid 20040846)
32. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C, Camussi G (2008) Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 294:F1185-F1194
33. Cooling LL, Walker KE, Gille T, Koerner TA (1998) Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun 66:4355-4366 (Pubitemid 28402712)
34. Coward RJ, Welsh GI, Yang J, Tasman C, Lennon R, Koziell A, Satchell S, Holman GD, Kerjaschki D, Tavare JM, Mathieson PW, Saleem MA (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095-3102 (Pubitemid 43334361)
35. Creydt VP, Silberstein C, Zotta E, Ibarra C (2006) Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 8:410-419 (Pubitemid 43214603)
36. D'Agati VD (2008) Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73:399-406 (Pubitemid 351186280)
37. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604-1611 (Pubitemid 41208572)
38. Devarajan P (2010) Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 15:419-428
39. Dowling TC, Chavaillaz PA, Young DG, Melton-Celsa A, O'Brien A, Thuning-Roberson C, Edelman R, Tacket CO (2005) Phase 1 safety and pharmacokinetic study of chimeric murinehuman monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers. Antimicrob Agents Chemother 49:1808-1812 (Pubitemid 40631593)
40. Dran GI, Fernandez GC, Rubel CJ, Bermejo E, Gomez S, Meiss R, Isturiz MA, Palermo MS (2002) Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney Int 62:1338-1348
41. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129-1136 (Pubitemid 351398487)
42. Ergonul Z, Clayton F, Fogo AB, Kohan DE (2003a) Shiga toxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18:246-253 (Pubitemid 36790049)
43. Ergonul Z, Hughes AK, Kohan DE (2003b) Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin 1. J Infect Dis 187:154-158 (Pubitemid 36034486)
44. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453-2468 (Pubitemid 33051968)
45. Falguieres T, Romer W, Amessou M, Afonso C, Wolf C, Tabet JC, Lamaze C, Johannes L (2006) Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. Febs J 273:5205-5218 (Pubitemid 44673308)
46. Fernandez GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL (2003) Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol 18:1066-1068 (Pubitemid 37236224)
47. Fernandez GC, Gomez SA, Rubel CJ, Bentancor LV, Barrionuevo P, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2005) Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol 20:1306-1314 (Pubitemid 41222979)
48. Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS (2006) Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 146:76-84 (Pubitemid 44393841)
49. Fernandez GC, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Lopez L, Ramirez F, Diaz M, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2007) The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome. Pediatr Res 61:123-128 (Pubitemid 46352328)
50. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM (1992) Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42:951-956
51. Fogo AB (2009) The multi-talented podocyte. Nephrol Dial Transplant 24:3269-3270
52. Fong JS, Kaplan BS (1982) Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion". Blood 60:564-570 (Pubitemid 12027130)
53. Forsyth KD, Simpson AC, Fitzpatrick MM, Barratt TM, Levinsky RJ (1989) Neutrophilmediated endothelial injury in haemolytic uraemic syndrome. Lancet 2:411-414 (Pubitemid 19195959)
54. Fujii J, Wood K, Matsuda F, Carneiro-Filho BA, Schlegel KH, Yutsudo T, Binnington-Boyd B, Lingwood CA, Obata F, Kim KS, Yoshida S, Obrig T (2008) Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun 76:3679-3689
55. Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79:1329-1337
56. Garcia A, Bosques CJ, Wishnok JS, Feng Y, Karalius BJ, Butterton JR, Schauer DB, Rogers AB, Fox JG (2006) Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis 193:1125-1134
57. Gear AR, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10:335-350 (Pubitemid 39004260)
58. Gear ARL, Suttitanamongkol D, Viisoreanu D, Polanowska Grabowska RK, Raha S, Camerini D (2001) Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97:937-945 (Pubitemid 32154277)
59. Geelen JM, van der Velden TJ, Te Loo DM, Boerman OC, van den Heuvel LP, Monnens LA (2007a) Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrol Dial Transplant 22:749-755 (Pubitemid 46351681)
60. Geelen JM, van der Velden TJ, van den Heuvel LP, Monnens LA (2007b) Interactions of Shigalike toxin with human peripheral blood monocytes. Pediatr Nephrol 22:1181-1187
61. Geelen J, Valsecchi F, van der Velden T, van den Heuvel L, Monnens L, Morigi M (2008) Shigatoxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate. Nephrol Dial Transplant 23:3091-3095
62. Ghosh SA, Polanowska-Grabowska RK, Fujii J, Obrig T, Gear AR (2004) Shiga toxin binds to activated platelets. J Thromb Haemost 2:499-506 (Pubitemid 40185664)
63. Giardino L, Armelloni S, Corbelli A, Mattinzoli D, Zennaro C, Guerrot D, Tourrel F, Ikehata M, Li M, Berra S, Carraro M, Messa P, Rastaldi MP (2009) Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 20: 1929-1940
64. Goncalves GM, Castoldi A, Braga TT, Camara NO (2011) New roles for innate immune response in acute and chronic kidney injuries. Scand J Immunol 73:428-435
65. Grant DS, Kleinman HK, Martin GR (1990) The role of basement membranes in vascular development. Ann N Y Acad Sci 588:61-72 (Pubitemid 20203368)
66. Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Keepers TR, Obrig T, Gear AR (2005a) Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thromb Haemost 94:1019-1027 (Pubitemid 41645944)
67. Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR (2005b) Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun 73:8306-8316 (Pubitemid 41740321)
68. Habib R (1992) Pathology of the hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds) Thrombotic thrombocytopenic purpura. Decker, New York, pp 315-353
69. Hakomori SI (2000) Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J 17:143-151
70. Henao DE, Mathieson PW, Saleem MA, Bueno JC, Cadavid A (2007) A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant 22:1477 (Pubitemid 47072243)
71. Hirschberg R, Wang S, Mitu GM (2008) Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 331:485-493
72. Hoch J, Jarrell BE, Schneider T, Williams SK (1989) Endothelial cell interactions with native surfaces. Ann Vasc Surg 3:153-159
73. Hoey DE, Sharp L, Currie C, Lingwood CA, Gally DL, Smith DG (2003) Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol 5:85-97 (Pubitemid 36395123)
74. Huang J, Motto DG, Bundle DR, Sadler JE (2010) Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. Blood 116:3653-3659
75. Hughes AK, Stricklett PK, Kohan DE (1998a) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54:426-437 (Pubitemid 28357405)
76. Hughes AK, Stricklett PK, Kohan DE (1998b) Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int 54:1093-1106 (Pubitemid 28449896)
77. Hughes AK, Stricklett PK, Schmid D, Kohan DE (2000) Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57:2350-2359 (Pubitemid 30340734)
78. Hughes AK, Ergonul Z, Stricklett PK, Kohan DE (2002) Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. J Am Soc Nephrol 13:2239-2245 (Pubitemid 34925234)
79. Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM (1997) Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child 77:145-147 (Pubitemid 27398218)
80. Itoh H, Cicala C, Douglas GJ, Page CP (1996) Platelet accumulation induced by bacterial endotoxin in rats. Thromb Res 83:405-419 (Pubitemid 26328714)
81. Izzedine H, Massard C, Spano JP, Goldwasser F, Khayat D, Soria JC (2010) VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management. Eur J Cancer 46:439-448
82. Jandhyala DM, Ahluwalia A, Obrig T, Thorpe CM (2008) ZAK: a MAP3Kinase that transduces Shiga toxin-and ricin-induced proinflammatory cytokine expression. Cell Microbiol 10:1468-1477 (Pubitemid 351837267)
83. Jelacic S, Wobbe CL, Boster DR, Ciol MA, Watkins SL, Tarr PI, Stapleton AE (2002) ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis 185:214-219 (Pubitemid 34056445)
84. Jeong KI, Chapman-Bonofiglio S, Singh P, Lee J, Tzipori S, Sheoran AS (2010) In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2. BMC Immunol 11:16
85. Johannes L, Romer W (2010) Shiga toxins-from cell biology to biomedical applications. Nat Rev Microbiol 8:105-116
86. Kamitsuji H, Nonami K, Murakami T, Ishikawa N, Nakayama A, Umeki Y (2000) Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli. Clin Nephrol 53:319-324 (Pubitemid 30304163)
87. Kaneko K, Kiyokawa N, Ohtomo Y, Nagaoka R, Yamashiro Y, Taguchi T, Mori T, Fujimoto J, Takeda T (2001) Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron 87:182-185 (Pubitemid 32215832)
88. Karch H, Bitzan M, Pietsch R, Stenger KO, von Wulffen H, Heesemann J, Dusing R (1988) Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microb Pathog 5:215-221 (Pubitemid 18263596)
89. Karch H, Tarr PI, Bielaszewska M (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295:405-418 (Pubitemid 41225453)
90. Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C (1995) Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 9:694-699 (Pubitemid 26003669)
91. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C (1997) The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 175:611-620 (Pubitemid 27086165)
92. Karpman D, Hakansson A, Perez MT, Isaksson C, Carlemalm E, Caprioli A, Svanborg C (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66:636-644 (Pubitemid 28074206)
93. Karpman D, Papadopoulou D, Nilsson K, Sjogren AC, Mikaelsson C, Lethagen S (2001) Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97:3100-3108
94. Karpman D, Sartz L, Johnson S (2010) Pathophysiology of typical hemolytic uremic syndrome. Semin Thromb Hemost 36:575-585
95. Katayama M,HandaM,Araki Y,Ambo H, KawaiY,WatanabeK, Ikeda Y(1993) Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 84:702-710 (Pubitemid 23248065)
96. Kaye SA, Obrig TG (1995) Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome. Thromb Res 79:415-421
97. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG (1993) Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 61:3886-3891 (Pubitemid 23260063)
98. Keepers TR, Psotka MA, Gross LK, Obrig TG (2006) A murine model of HUS: shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404-3414 (Pubitemid 44865283)
99. Keepers TR, Gross LK, Obrig TG (2007) Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun 75:1229-1236 (Pubitemid 46385814)
100. Khan F, Proulx F, Lingwood CA (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75: 1209-1216
101. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW (2001) Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59:2243-2249 (Pubitemid 32467617)
102. Kodama T, Nagayama K, Yamada K, Ohba Y, Akeda Y, Honda T (1999) Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro. Med Microbiol Immunol 188:73-78
103. Kurioka T, Yunou Y, Kita E (1998) Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 66: 1726-1734 (Pubitemid 128471540)
104. Lalka SG, Oelker LM, Malone JM, Duhamel RC, Kevorkian MA, Raper BA, Nixon JC, Etchberger KJ, Dalsing MC, Cikrit DF et al (1989) Acellular vascular matrix: a natural endothelial cell substrate. Ann Vasc Surg 3:108-117
105. Lammle B, Griffin JH (1985) Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Clin Haematol 14:281-342 (Pubitemid 15038454)
106. Li X, Pabla N, Wei Q, Dong G, Messing RO, Wang CY, Dong Z (2010) PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. J Am Soc Nephrol 21:1115-1124
107. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE, Karlsson KA (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262:1779-1785
108. Lingwood CA (1993) Verotoxins and their glycolipid receptors. Adv Lipid Res 25:189-211
109. Lingwood CA (1994) Verotoxin-binding in human renal sections. Nephron 66:21-28 (Pubitemid 23355572)
110. Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4:147-153 (Pubitemid 26135305)
111. Lingwood CA, Mylvaganam M (2003) Lipid modulation of glycosphingolipid (GSL) receptors: soluble GSL mimics provide new probes of GSL receptor function. Methods Enzymol 363:264-283 (Pubitemid 37267676)
112. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, Karmali M (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262:8834-8839
113. Lingwood CA, Binnington B, Manis A, Branch DR (2010a) Globotriaosyl ceramide receptor function-where membrane structure and pathology intersect. FEBS Lett 584:1879-1886
114. Lingwood CA, Manis A, Mahfoud R, Khan F, Binnington B, Mylvaganam M (2010b) New aspects of the regulation of glycosphingolipid receptor function. Chem Phys Lipids 163:27-35
115. Liu J, Akahoshi T, Sasahana T, Kitasato H, Namai R, Sasaki T, Inoue M, Kondo H (1999a) Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7. Infect Immun 67:6203-6205 (Pubitemid 29508161)
116. Liu XH, Lingwood CA, Ray PE (1999b) Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease. Kidney Int 55: 554-561 (Pubitemid 29082881)
117. Lopez EL, Contrini MM, Glatstein E, Gonzalez Ayala S, Santoro R, Allende D, Ezcurra G, Teplitz E, Koyama T, Matsumoto Y, Sato H, Sakai K, Hoshide S, Komoriya K, Morita T, Harning R, Brookman S (2010) Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli. Antimicrob Agents Chemother 54:239-243
118. Louise CB, Obrig TG (1991) Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59:4173-4179
119. Louise CB, Obrig TG (1992) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60:1536-1543
120. Louise CB, Obrig TG (1994) Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. Microvasc Res 47:377-387 (Pubitemid 24207594)
121. Louise CB, Tran MC, Obrig TG (1997) Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB. Infect Immun 65:3337-3344 (Pubitemid 27342419)
122. Mahfoud R, Manis A, Binnington B, Ackerley C, Lingwood CA (2010) A major fraction of glycosphingolipids in model and cellular cholesterol containing membranes are undetectable by their binding proteins. J Biol Chem 285:36049-36059
123. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101:841-843 (Pubitemid 30117876)
124. Marshall SM (2007) The podocyte: a potential therapeutic target in diabetic nephropathy? Curr Pharm Des 13:2713-2720 (Pubitemid 47423663)
125. Martin W, Furchgott RF, Villani GM, Jothianandan D (1986) Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 237:529-538 (Pubitemid 16092813)
126. McCluer RH, Williams MA, Gross SK, Meisler MH (1981) Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes. J Biol Chem 256:13112-13120 (Pubitemid 12131975)
127. McNeilly TN, Mitchell MC, Rosser T, McAteer S, Low JC, Smith DG, Huntley JF, Mahajan A, Gally DL (2010) Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. Vaccine 28:1422-1428
128. Melton-Celsa AR, O'Brien AD (2003) Animal models for STEC-mediated disease. Methods Mol Med 73:291-305
129. Miura Y, Sakaki A, Kamihira M, Iijima S, Kobayashi K (2006) A globotriaosylceramide (Gb3Cer) mimic peptide isolated from phage display library expressed strong neutralization to Shiga toxins. Biochim Biophys Acta 1760:883-889 (Pubitemid 43816183)
130. Mkaddem SB, Bens M, Vandewalle A (2010) Differential activation of Toll-like receptormediated apoptosis induced by hypoxia. Oncotarget 1:741-750
131. Moake J (2009) Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol 22:567-576
132. Mohawk KL, Melton-Celsa AR, Robinson CM, O'Brien AD (2010) Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. Vaccine 28:4777-4785
133. Morigi M, Micheletti G, Figliuzzi M, Imberti B, Karmali MA, Remuzzi A, Remuzzi G, Zoja C (1995) Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86:4553-4558
134. Morigi M, Galbusera M, Binda E, Imberti B, Gastoldi S, Remuzzi A, Zoja C, Remuzzi G (2001) Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 98:1828-1835
135. Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965-1975 (Pubitemid 351181958)
136. Murata K, Higuchi T, Takada K, Oida K, Horie S, Ishii H (2006) Verotoxin-1 stimulation of macrophage-like THP-1 cells up-regulates tissue factor expression through activation of c-Yes tyrosine kinase: possible signal transduction in tissue factor up-regulation. Biochim Biophys Acta 1762:835-843 (Pubitemid 44403050)
137. Muthing J, Schweppe CH, Karch H, Friedrich AW (2009) Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 101:252-264
138. Nestoridi E, Kushak RI, Duguerre D, Grabowski EF, Ingelfinger JR (2005a) Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int 67:2254-2266 (Pubitemid 41623385)
139. Nestoridi E, Tsukurov O, Kushak RI, Ingelfinger JR, Grabowski EF (2005b) Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost 3:752-762 (Pubitemid 41647890)
140. Nevard CH, Jurd KM, Lane DA, Philippou H, Haycock GB, Hunt BJ (1997) Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost 78:1450-1455 (Pubitemid 27519388)
141. Nevard CH, Blann AD, Jurd KM, Haycock GB, Hunt BJ (1999) Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome. Pediatr Nephrol 13:487-492 (Pubitemid 29348703)
142. Newburg DS, Chaturvedi P, Lopez EL, Devoto S, Fayad A, Cleary TG (1993) Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. J Infect Dis 168:476-479 (Pubitemid 23210633)
143. Nishikawa K, Watanabe M, Kita E, Igai K, Omata K, Yaffe MB, Natori Y (2006) A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. Faseb J 20:2597-2599
144. Nolasco LH, Turner NA, Bernardo A, Tao Z, Cleary TG, Dong JF, Moake JL (2005) Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 106: 4199-4209 (Pubitemid 41775927)
145. Obata F (2010) Influence of Escherichia coli shiga toxin on the mammalian central nervous system. Adv Appl Microbiol 71:1-19
146. Obata F, Obrig T (2010) Distribution of Gb(3) immunoreactivity in the mouse central nervous system. Toxins (Basel) 2:1997-2006
147. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S, Obrig TG (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198:1398-1406
148. Obrig TG (2010) Escherichia coli shiga toxin mechanisms of action in renal disease. Toxins (Basel) 2:2769-2794
149. Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373-2378
150. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484-15488 (Pubitemid 23222039)
151. Ohmi K, Kiyokawa N, Takeda T, Fujimoto J (1998) Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 251:137-141 (Pubitemid 28498076)
152. Okuda T, Tokuda N, Numata S, Ito M, Ohta M, Kawamura K, Wiels J, Urano T, Tajima O, Furukawa K (2006) Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem 281:10230-10235 (Pubitemid 43864560)
153. O'Loughlin EV, Robins-Browne RM (2001) Effect of shiga toxin and shiga-like toxins on eukaryotic cells. Microbes Infect 3:493-507 (Pubitemid 32497278)
154. Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Wurzner R (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182:6394-6400
155. Paixao-Cavalcante D, Botto M, Cook HT, Pickering MC (2009) Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice. Clin Exp Immunol 155:339-347
156. Palermo M, Alves-Rosa F, Rubel C, Fernandez GC, Fernandez-Alonso G, Alberto F, Rivas M, Isturiz M (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77-83 (Pubitemid 30064594)
157. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, Viltard M, Yu W, Forster CS, Gong G, Liu Y, Kulkarni R, Mori K, Kalandadze A, Ratner AJ, Devarajan P, Landry DW, D'Agati V, Lin CS, Barasch J (2011) The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17:216-222
158. Pearson JD (2000) Normal endothelial cell function. Lupus 9:183-188 (Pubitemid 30199260)
159. Peti-Peterdi J, Sipos A (2010) A high-powered view of the filtration barrier. J Am Soc Nephrol 21:1835-1841
160. Petruzziello TN, Mawji IA, Khan M, Marsden PA (2009) Verotoxin biology: molecular events in vascular endothelial injury. Kidney Int Suppl 112:S17-S19
161. Picken MM (2009) The role of mesangial homeostasis in glomerular injury progression: hope for mesangial sclerosis reversal. Kidney Int 75:574-576
162. Pijpers AH, van Setten PA, van den Heuvel LP, Assmann KJ, Dijkman HB, Pennings AH, Monnens LA, van Hinsbergh VW (2001) Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12:767-778 (Pubitemid 32246705)
163. Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB (2004) Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22:362-369 (Pubitemid 37510266)
164. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG (2009) Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77:959-969
165. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, van der Poll T, Florquin S, Leemans JC (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21:1299-1308
166. Quaggin SE (2009) Genetic susceptibility to HIV-associated nephropathy. J Clin Invest 119:1085-1089
167. Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058 (Pubitemid 17154788)
168. Rao LV, Rapaport SI, Bajaj SP (1986) Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood 68:685-691 (Pubitemid 16008171)
169. Robinson LA, Hurley RM, Lingwood C, Matsell DG (1995) Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Pediatr Nephrol 9:700-704 (Pubitemid 26003670)
170. Robson WL, Fick GH, Wilson PC (1988) Prognostic factors in typical postdiarrhea hemolyticuremic syndrome. Child Nephrol Urol 9:203-207 (Pubitemid 19200236)
171. Robson WL, Leung AK, Fick GH, McKenna AI (1992) Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 62:296-299
172. Roche JK, Keepers TR, Gross LK, Seaner RM, Obrig TG (2007) CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 170:526-537 (Pubitemid 47339390)
173. Rosner MH (2009) Urinary biomarkers for the detection of renal injury. Adv Clin Chem 49:73-97
174. Rutjes NW, Binnington BA, Smith CR, Maloney MD, Lingwood CA (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int 62:832-845 (Pubitemid 35316712)
175. Saluk-Juszczak J, Wachowicz B, Kaca W (1999) Stimulatory effects of endotoxin on the platelet secretory process. Microbios 99:45-53 (Pubitemid 129634620)
176. Sandvig K, Bergan J, Dyve AB, Skotland T, Torgersen ML (2009) Endocytosis and retrograde transport of Shiga toxin. Toxicon
177. Sassetti B, Vizcarguenaga MI, Zanaro NL, Silva MV, Kordich L, Florentini L, Diaz M, Vitacco M, Sanchez Avalos JC (1999) Hemolytic uremic syndrome in children: platelet aggregation and membrane glycoproteins. J Pediatr Hematol Oncol 21:123-128 (Pubitemid 30303875)
178. Sauter KA, Melton-Celsa AR, Larkin K, Troxell ML, O'Brien AD, Magun BE (2008) Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect Immun 76:4469-4478
179. Savage B, Shattil SJ, Ruggeri ZM (1992) Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 267:11300-11306
180. Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179-1187
181. Schmidt H, Karch H, Beutin L (1994) The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. FEMS Microbiol Lett 117:189-196 (Pubitemid 24097098)
182. Shankland SJ (2006) The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69:2131-2147 (Pubitemid 43882099)
183. Shayman JA, Radin NS (1991) Structure and function of renal glycosphingolipids. Am J Physiol 260:F291-F302
184. Shigematsu H, Dikman SH, Churg J, Grishman E, Duffy JL (1976) Mesangial involvement in hemolytic-uremic syndrome. A light and electron microscopic study. Am J Pathol 85:349-362
185. Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr (2001) Response to shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 21:420-425 (Pubitemid 34701853)
186. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB (2003) Response to shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92-96 (Pubitemid 41490292)
187. Siegler RL, Pysher TJ, Tesh VL, Noris M, Cassis P, Taylor FB Jr (2005) Reduced nitric oxide bioavailability in a baboon model of Shiga toxin mediated hemolytic uremic syndrome (HUS). Ren Fail 27:635-641 (Pubitemid 41216323)
188. Silberstein C, Pistone Creydt V, Gerhardt E, Nunez P, Ibarra C (2008) Inhibition of water absorption in human proximal tubular epithelial cells in response to shiga toxin-2. Pediatr Nephrol 23:1981-1990
189. Simon M, Cleary TG, Hernandez JD, Abboud HE (1998) Shiga toxin 1 elicits diverse biologic responses in mesangial cells. Kidney Int 54:1117-1127 (Pubitemid 28449898)
190. Sison K, Eremina V, Baelde H, Min W, Hirashima M, Fantus IG, Quaggin SE (2010) Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 21:1691-1701
191. Smith PS, Fanning JC, Aarons I (1989) The structure of the normal human glomerular basement membrane. Ultrastructural localization of type IV collagen and laminin. Pathology 21:254-258 (Pubitemid 20042874)
192. Smith DC, Sillence DJ, Falguieres T, Jarvis RM, Johannes L, Lord JM, Platt FM, Roberts LM (2006a) The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17:1375-1387 (Pubitemid 43376557)
193. Smith MJ, Teel LD, Carvalho HM, Melton-Celsa AR, O'Brien AD (2006b) Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2. Vaccine 24:4122-4129
194. Sood A, Mathew R, Trachtman H (2001) Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin. Biochem Biophys Res Commun 283:36-41 (Pubitemid 32912533)
195. Spitalnik PF, Spitalnik SL (1995) The P blood group system: biochemical, serological, and clinical aspects. Transfus Med Rev 9:110-122
196. Ståhl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D (2006) Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108:167-176 (Pubitemid 43990625)
197. Ståhl AL, Sartz L, Nelsson A, Bekassy ZD, Karpman D (2009) Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 4:e6990
198. Ståhl AL, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117:5503-5513
199. Stearns-Kurosawa DJ, Collins V, Freeman S, Tesh VL, Kurosawa S (2010) Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli. Infect Immun 78:2497-2504
200. Stricklett PK, Hughes AK, Kohan DE (2005) Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells. J Infect Dis 191:461-471 (Pubitemid 40139772)
201. Sugatani J, Komiyama N, Mochizuki T, Hoshino M, Miyamoto D, Igarashi T, Hoshi S, Miwa M (2002) Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with polyuria. Life Sci 71:171-189 (Pubitemid 34595436)
202. Szabady RL, Lokuta MA, Walters KB, Huttenlocher A, Welch RA (2009) Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7. PLoS Pathog 5:e1000320
203. Takeuchi O, Akira S (2001) Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1:625-635 (Pubitemid 32206524)
204. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086 (Pubitemid 40386785)
205. Taylor CM, Milford DV, Rose PE, Roy TC, Rowe B (1990) The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome. Pediatr Nephrol 4:59-61 (Pubitemid 20057515)
206. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL (1999) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285-1299 (Pubitemid 29169762)
207. Tazzari PL, Ricci F, Carnicelli D, Caprioli A, Tozzi AE, Rizzoni G, Conte R, Brigotti M (2004) Flow cytometry detection of shiga toxins in the blood from children with hemolytic uremic syndrome. Cytom B Clin Cytom 61:40-44 (Pubitemid 39223369)
208. Te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW (2000) Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:3396-3402 (Pubitemid 30428469)
209. Te Loo DM, van Hinsbergh VW, van den Heuvel LP, Monnens LA (2001) Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol 12:800-806 (Pubitemid 32246708)
210. Te Loo DM, Monnens L, van der Velden T, Karmali M, van den Heuvel L, van Hinsbergh V (2006) Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells. Pediatr Nephrol 21:1815-1823 (Pubitemid 44741158)
211. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien AD (1991) Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352
212. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O'Brien AD, Samuel JE (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392-3402 (Pubitemid 23223431)
213. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S (2008) Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19:495-502 (Pubitemid 351355393)
214. Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920-1924
215. Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J, Jain A, Bullington N, Devarajan P (2006) Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 21:989-994 (Pubitemid 43885099)
216. Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354:1387-1401
217. Tsai HM, Chandler WL, Sarode R, Hoffman R, Jelacic S, Habeeb RL, Watkins SL, Wong CS, Williams GD, Tarr PI (2001) von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49:653-659 (Pubitemid 32390854)
218. Turi S, Nemeth I, Vargha I, Matkovics B (1994) Oxidative damage of red blood cells in haemolytic uraemic syndrome. Pediatr Nephrol 8:26-29 (Pubitemid 24042361)
219. Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H (2004) Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 17:926-941 (Pubitemid 39372524)
220. Table of contents Uchida H, Kiyokawa N, Horie H, Fujimoto J, Takeda T (1999) The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 45:133-137 (Pubitemid 29016787)
221. van de Kar NC, Monnens LA, Karmali MA, van Hinsbergh VW (1992) Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764
222. van de Kar NC, Monnens LA, Van Hinsbergh VW (1993) Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome. Behring Inst Mitt 92:202-209
223. van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA (1994) The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. Pediatr Res 36:257-264 (Pubitemid 24222490)
224. Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ (1998) Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int 54: 1324-1330 (Pubitemid 28449922)
225. van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183 (Pubitemid 26230685)
226. van Setten PA, van Hinsbergh VW, Van den Heuvel LP, van der Velden TJ, van de Kar NC, Krebbers RJ, Karmali MA, Monnens LA (1997a) Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 8:1877-1888
227. van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA (1997b) Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 51:1245-1256 (Pubitemid 27186553)
228. van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA (1998) Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res 43:759-767 (Pubitemid 28243646)
229. Vandewalle A (2008) Toll-like receptors and renal bacterial infections. Chang Gung Med J 31:525-537
230. Vaughan MR, Quaggin SE (2008) How do mesangial and endothelial cells form the glomerular tuft? J Am Soc Nephrol 19:24-33
231. Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, Friedlander G, Barasch J, Terzi F (2010) Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 120:4065-4076
232. Viisoreanu D, Polanowska-Grabowska R, Suttitanamongkol S, Obrig TG, Gear AR (2000) Human platelet aggregation is not altered by Shiga toxins 1 or 2. Thromb Res 98:403-410 (Pubitemid 30319313)
233. Wachowicz B, Saluk J, Kaca W (1998) Response of blood platelets to Proteus mirabilis lipopolysaccharide. Microbiol Immunol 42:47-49 (Pubitemid 28071151)
234. Waddell T, Cohen A, Lingwood CA (1990) Induction of verotoxin sensitivity in receptordeficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci USA 87:7898-7901
235. Wahome PG, Bai Y, Neal LM, Robertus JD, Mantis NJ (2010) Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen. Toxicon 56:526-534
236. Warnier M, Romer W, Geelen J, Lesieur J, Amessou M, van den Heuvel L, Monnens L, Johannes L (2006) Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. Kidney Int 70:2085-2092 (Pubitemid 44871370)
237. Watanabe-Takahashi M, Sato T, Dohi T, Noguchi N, Kano F, Murata M, Hamabata T, Natori Y, Nishikawa K (2010) An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin. Infect Immun 78:177-183
238. Williams JM, Boyd B, Nutikka A, Lingwood CA, Barnett Foster DE, Milford DV, Taylor CM (1999) A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 105:47-57 (Pubitemid 29090347)
239. Wilson C, Foster GH, Bitzan M (2005) Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2. Infection 33: 362-367 (Pubitemid 41552014)
240. Winter KR, Stoffregen WC, Dean-Nystrom EA (2004) Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun 72:6680-6684 (Pubitemid 39425452)
241. Wolski VM, Soltyk AM, Brunton JL (2002) Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice. Microb Pathog 32:263-271 (Pubitemid 34969584)
242. Wu X, He Y, Jing Y, Li K, Zhang J (2010) Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. Omics 14:61-73
243. Yamamoto M, Akira S (2010) Lipid A receptor TLR4-Mediated signaling pathways. Adv Exp Med Biol 667:59-68
244. Yannariello-Brown J, Wewer U, Liotta L, Madri JA (1988) Distribution of a 69-kD lamininbinding protein in aortic and microvascular endothelial cells: modulation during cell attachment, spreading, and migration. J Cell Biol 106:1773-1786
245. Zanchi C, Zoja C, Morigi M, Valsecchi F, Liu XY, Rottoli D, Locatelli M, Buelli S, Pezzotta A, Mapelli P, Geelen J, Remuzzi G, Hawiger J (2008) Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J Immunol 181:1460-1469
246. Zipfel PF, Heinen S, Skerka C (2010) Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens 19:372-378
247. Zoja C, Morigi M, Remuzzi G (2001) The role of the endothelium in hemolytic uremic syndrome. J Nephrol 14(4):S58-S62 (Pubitemid 33743242)
248. Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G, Morigi M (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 62:846-856 (Pubitemid 35316713)
249. Zoja C, Morigi M, Remuzzi G (2003) Proteinuria and phenotypic change of proximal tubular cells. J Am Soc Nephrol 14(1):S36-S41 (Pubitemid 36687038)
250. Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25:2231-2240